Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

Commentary Comment: Frequency of heat waves should have us in a cold sweat The U.S. is unprepared for heat waves’ effects and is going the wrong way on the climate crisis behind them. Saturday ...

Know how the 8:4:3 rule and Rule of 72 can maximize your mutual fund returns. Learn about the power of compounding, disciplined investing, and new mutual fund regulations. Understand how these ...

That calls the FDA's decision to restrict compounding of tirzepatide "a reckless and arbitrary decision […] to deprive patients of a vital treatment for type 2 diabetes and obesity." ...

You’ve no doubt heard of high-yield savings accounts, but what are they exactly, and should you open one? If you’re keeping money you don’t need right now in a checking account or ...

CNBC Select looks at the advantages and disadvantages of putting your money in a high-yield savings account.

However, Leqembi now faces its first competition in the anti-amyloid category following the FDA approval of Eli Lilly's Kisunla (donanemab), which offers a reduced dosing frequency, meaning it ...